Healthcare Professionals' Working Party
Submitted by Anonymous (not verified) on 24 July 2026 - 13:11
Healthcare Professionals' Working Party
Summary report - Network Data Steering Group and industry stakeholders annual meeting
Submitted by Anonymous (not verified) on 24 July 2026 - 13:00
Summary report - Network Data Steering Group and industry stakeholders annual meeting
Agenda - Network Data Steering Group and industry stakeholders annual meeting
Submitted by Anonymous (not verified) on 24 July 2026 - 12:58
Agenda - Network Data Steering Group and industry stakeholders annual meeting
Network Data Steering Group and industry stakeholders annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 14 July 2026
Submitted by Anonymous (not verified) on 24 July 2026 - 12:48
Network Data Steering Group and industry stakeholders annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 14 July 2026
Concept paper on the quality and safety aspects of RNA interference and RNA antisense oligonucleotide therapies as veterinary medicinal products
Submitted by Anonymous (not verified) on 24 July 2026 - 12:39
Concept paper on the quality and safety aspects of RNA interference and RNA antisense oligonucleotide therapies as veterinary medicinal products
Guideline on data requirements for changes to the strain composition of authorised equine influenza vaccines in line with WOAH recommendations - Revision 1
Submitted by Anonymous (not verified) on 24 July 2026 - 12:34
Guideline on data requirements for changes to the strain composition of authorised equine influenza vaccines in line with WOAH recommendations - Revision 1
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026
Submitted by Anonymous (not verified) on 24 July 2026 - 11:00
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026
Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn
Submitted by Anonymous (not verified) on 24 July 2026 - 11:00
Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Cavoley, pegfilgrastim, Status: Opinion
Submitted by Anonymous (not verified) on 24 July 2026 - 11:00
Human medicines European public assessment report (EPAR): Cavoley, pegfilgrastim, Status: Opinion
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion
Submitted by Anonymous (not verified) on 24 July 2026 - 11:00
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion